[1]
“PHARMACOBIOCHEMICAL EVALUATION OF RENOPROTECTIVE AGENTS IN CHRONIC KIDNEY DISEASE”, Genetics and Mol. Res., May 2026, doi: 10.4238/s9gmbg98.